A 25-year-old female comes to the pharmacy inquiring about the 9vHPV series. What would be the recommended vaccination series?

The recommended vaccination series for the 9vHPV vaccine (Gardasil 9) in a 25-year-old female is indeed a three-dose series administered intramuscularly at specific intervals: the first dose at the initial visit (0 months), the second dose 1 to 2 months later, and the third dose 6 months after the first dose.

This three-dose schedule is typically recommended for individuals who begin the vaccination series between the ages of 15 and 26. The purpose of the series is to ensure robust immunity against the high-risk strains of human papillomavirus (HPV) that can lead to various cancers, including cervical cancer.

Using this specific schedule allows the body to develop a sufficient immune response by providing booster doses that enhance and prolong immunity. The timing for the doses is designed to allow for optimal immune system activation and memory response, which is crucial for effective long-term protection against HPV-related diseases.